Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $10.3 million.

  • Macrogenics' Current Deferred Revenue fell 5580.06% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 5580.06%. This contributed to the annual value of $16.3 million for FY2024, which is 2462.7% down from last year.
  • According to the latest figures from Q3 2025, Macrogenics' Current Deferred Revenue is $10.3 million, which was down 5580.06% from $7.9 million recorded in Q2 2025.
  • Over the past 5 years, Macrogenics' Current Deferred Revenue peaked at $25.6 million during Q1 2022, and registered a low of $3.5 million during Q1 2021.
  • For the 5-year period, Macrogenics' Current Deferred Revenue averaged around $15.3 million, with its median value being $16.3 million (2021).
  • Per our database at Business Quant, Macrogenics' Current Deferred Revenue skyrocketed by 62619.32% in 2022 and then plummeted by 6694.94% in 2025.
  • Macrogenics' Current Deferred Revenue (Quarter) stood at $20.6 million in 2021, then plummeted by 51.62% to $10.0 million in 2022, then skyrocketed by 116.77% to $21.7 million in 2023, then decreased by 24.63% to $16.3 million in 2024, then plummeted by 36.87% to $10.3 million in 2025.
  • Its Current Deferred Revenue was $10.3 million in Q3 2025, compared to $7.9 million in Q2 2025 and $15.6 million in Q1 2025.